Atorvastatin

An HMG-CoA reductase inhibitor (statin) that lowers LDL cholesterol and reduces cardiovascular risk.

The exam loves the muscle/kidney follow-up: a patient reports new muscle aches, dark or “tea-colored” urine, and weakness — the priority is to hold the dose and notify the provider for a creatine kinase (CK), because that picture suggests rhabdomyolysis, not a benign ache. A second favorite is timing and food: counsel patients to avoid large amounts of grapefruit juice, which inhibits CYP3A4 and can raise drug levels. Atorvastatin’s long half-life lets it be taken any time of day, unlike short-acting agents (simvastatin, lovastatin) dosed at bedtime. For childbearing-age patients, note the FDA removed the blanket pregnancy contraindication in 2021, but statins are still stopped in most pregnancies — a high-yield distractor. (Some older question banks still label statins pregnancy “Category X” / absolutely contraindicated.)

The classic trap is lumping atorvastatin with metoprolol and lisinopril as “the heart drugs.” Only atorvastatin targets cholesterol, so a falling LDL — not a falling pulse or blood pressure — confirms it is working. Don’t apply the apical-pulse hold (metoprolol) or the dry cough/hyperkalemia warning (lisinopril) here.

PlayPrepHQ study notes are written and reviewed against primary exam sources. How we create & review content →

Related terms

Back to Pharmacological and Parenteral Therapies